Atrial Fibrillation

Every year around 75,000 Americans learn that they have atrial fibrillation (AFib)—the most common type of arrhythmia, or abnormal heart rhythm. While the abnormal heart rhythm itself isn't generally serious; abnormal blood flow and strain to the heart can lead to serious medical conditions. These conditions can be deadly—having AFib doubles a person's risk of death. 


Watch Living with AFib to get an overview of the disease and learn more about how you get it, how you treat it, and how you prevent AFib related strokes so you can live a long and healthy life with it.  Also available in Spanish.




This accompanying pocket film Stroke Prevention in AFib gives viewers more detail on how AFib causes stroke, the role frailty and fall risk should play in treatment decision-making, and the importance of stroke prevention. Also available in Spanish.




This brochure contains much of the information from the Living with AFib and Stroke Prevention in AFib pocket films, but in a brochure format that patients can take with them and refer to when learning about the disease and making treatment decisions.




Find out how much you know by testing your AFib knowlege with the Living with AFib quiz.





A survey of 500+ adults with AFib, age 65 and older, revealed that 25 percent were diagnosed during a regular check-up, 31 percent thought it was only a minor problem when diagnosed, 74 percent have been very satisfied with their treatment, and more. To read more insight and analysis from this survey from the Alliance released in January 2015, read here.

 Stroke Prevention in AFib

One of the most serious risks of AFib is stroke—around 15 percent of all strokes occur in people with AFib.  Anticoagulants—medications that make blood less likely to clot—reduce the risk of stroke in AFib patients by as much as 80 percent.  Unfortunately, while they lower stroke risk, they also raise the risk of bleeding, which can be serious and deadly if it occurs in the GI system or the brain.  Striking the right balance is critical to patient care.

The Alliance for Aging Research formed a task force for optimal treatment, made up of patient and professional groups who are raising awareness of the disease, pushing for new treatment tools, forming expert consensus on the existing tools, and advocating for optimal treatment of AFib patients.  Better treatment decisions will not only save lives, but will lead to better lives with fewer appointments, hospitalizations, and disabilities.

The Task Force has produced a number of important resources including an expert consensus document on optimal treatment, physician, and patient surveys that explored the gaps in communication that impact treatment, a Silver Book on thrombosis and AFib, a pocket guide to the guidelines, and submitted comments to federal agencies.